Heard JM - Search Results

1

Research activity and capability in the European reference network MetabERN.

Heard JM, Bellettato C, van Lingen C, Scarpa M; MetabERN collaboration group. Heard JM, et al. Orphanet J Rare Dis. 2019 May 29;14(1):119. doi: 10.1186/s13023-019-1091-8. Orphanet J Rare Dis. 2019. PMID: 31142374 Free PMC article.

2

The impact of COVID-19 on rare metabolic patients and healthcare providers: results from two MetabERN surveys.

Lampe C, Dionisi-Vici C, Bellettato CM, Paneghetti L, van Lingen C, Bond S, Brown C, Finglas A, Francisco R, Sestini S, Heard JM, Scarpa M; MetabERN collaboration group. Lampe C, et al. Among authors: heard jm. Orphanet J Rare Dis. 2020 Dec 3;15(1):341. doi: 10.1186/s13023-020-01619-x. Orphanet J Rare Dis. 2020. PMID: 33272301 Free PMC article.

3

Availability, accessibility and delivery to patients of the 28 orphan medicines approved by the European Medicine Agency for hereditary metabolic diseases in the MetabERN network.

Heard JM, Vrinten C, Schlander M, Bellettato CM, van Lingen C, Scarpa M; MetabERN collaboration group. Heard JM, et al. Orphanet J Rare Dis. 2020 Jan 6;15(1):3. doi: 10.1186/s13023-019-1280-5. Orphanet J Rare Dis. 2020. PMID: 31907071 Free PMC article.

4

Long-term and significant correction of brain lesions in adult mucopolysaccharidosis type VII mice using recombinant AAV vectors.

Bosch A, Perret E, Desmaris N, Heard JM. Bosch A, et al. Among authors: heard jm. Mol Ther. 2000 Jan;1(1):63-70. doi: 10.1006/mthe.1999.0005. Mol Ther. 2000. PMID: 10933913 Free article.

5

Improvement of erythropoiesis in beta-thalassemic mice by continuous erythropoietin delivery from muscle.

Bohl D, Bosch A, Cardona A, Salvetti A, Heard JM. Bohl D, et al. Among authors: heard jm. Blood. 2000 May 1;95(9):2793-8. Blood. 2000. PMID: 10779423 Free article.

6

Reversal of pathology in the entire brain of mucopolysaccharidosis type VII mice after lentivirus-mediated gene transfer.

Bosch A, Perret E, Desmaris N, Trono D, Heard JM. Bosch A, et al. Among authors: heard jm. Hum Gene Ther. 2000 May 20;11(8):1139-50. doi: 10.1089/10430340050015194. Hum Gene Ther. 2000. PMID: 10834616

7

Safe, efficient, and reproducible gene therapy of the brain in the dog models of Sanfilippo and Hurler syndromes.

Ellinwood NM, Ausseil J, Desmaris N, Bigou S, Liu S, Jens JK, Snella EM, Mohammed EE, Thomson CB, Raoul S, Joussemet B, Roux F, Chérel Y, Lajat Y, Piraud M, Benchaouir R, Hermening S, Petry H, Froissart R, Tardieu M, Ciron C, Moullier P, Parkes J, Kline KL, Maire I, Vanier MT, Heard JM, Colle MA. Ellinwood NM, et al. Among authors: heard jm. Mol Ther. 2011 Feb;19(2):251-9. doi: 10.1038/mt.2010.265. Epub 2010 Dec 7. Mol Ther. 2011. PMID: 21139569 Free PMC article.

8

alpha-L-Iduronidase transport in neurites.

Chen F, Vitry S, Hocquemiller M, Desmaris N, Ausseil J, Heard JM. Chen F, et al. Among authors: heard jm. Mol Genet Metab. 2006 Apr;87(4):349-58. doi: 10.1016/j.ymgme.2005.11.017. Epub 2006 Jan 24. Mol Genet Metab. 2006. PMID: 16439176

9

Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis.

Maréchal V, Prevost MC, Petit C, Perret E, Heard JM, Schwartz O. Maréchal V, et al. Among authors: heard jm. J Virol. 2001 Nov;75(22):11166-77. doi: 10.1128/JVI.75.22.11166-11177.2001. J Virol. 2001. PMID: 11602756 Free PMC article.

10

Gene therapy of the brain in the dog model of Hurler's syndrome.

Ciron C, Desmaris N, Colle MA, Raoul S, Joussemet B, Vérot L, Ausseil J, Froissart R, Roux F, Chérel Y, Ferry N, Lajat Y, Schwartz B, Vanier MT, Maire I, Tardieu M, Moullier P, Heard JM. Ciron C, et al. Among authors: heard jm. Ann Neurol. 2006 Aug;60(2):204-13. doi: 10.1002/ana.20870. Ann Neurol. 2006. PMID: 16718701

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

138 results

Search Page